Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

Sanofi to Cut 1,500-2,000 Jobs in France - Report

share with twitter share with LinkedIn share with facebook
share via e-mail
09/15/2012 | 02:11pm CEST

French pharmaceutical giant Sanofi SA (SAN.FR, SNY) will disclose cuts of between 1,500 and 2,000 jobs in France on Sept. 25, French newspaper Le Figaro reported Saturday, without citing sources.

The company plans to reduce its 28,000 payroll in France mainly through attrition, the newspaper said.

In July, Sanofi had said it planned to cut jobs at two French units in a bid to preserve the company's profitability, which has been put at risk by recent patent expirations and the economic recession in most of Europe. The company had said it would detail the job cuts in September.

At the time, French Industry Minister Arnaud Montebourg had criticized the company and said he wouldn't tolerate when profitable companies slash jobs.

A Sanofi spokesman didn't return a phone call seeking comments.

Newspaper Web site: http://www.lefigaro.fr

Write to Inti Landauro at inti.landauro@dowjones.com.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on SANOFI
08/19 SANOFI : New Hampshire to get $1 million in EpiPen settlement
08/19 SANOFI : Mylan Agrees to Pay $465 Million to Resolve False Claims Act Liability
08/19 Mindshare Wins Global Media Account For Pharmaceutical Giant Sanofi
08/18 SANOFI : EpiPen maker finalizes $465 million settlement
08/18 SANOFI AVENTIS PAKISTAN : Board of directors meeting of Sanofi - Aventis Pakista..
08/17 SANOFI : Mylan Agrees to Pay $465 Million to Resolve False Claims Act Liability
08/17 SANOFI : EpiPen maker finalizes settlement for government overcharges
08/17 SANOFI : and Regeneron end ten-year mAb collaboration
08/17 LEXICON PHARMACEUTICALS : builds case for Sanofi-partnered diabetes pill
08/16 INSIDER TRADING ACTIVITY MYOKARDIA, : MYOK) – Major Shareholder Bought 35..
More news
News from SeekingAlpha
08/17 House Dems look into MS med prices, seven drug makers contacted
08/15 Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q2 2017 Update
08/14 Fibrogen And Galapagos Raise Lung Disease Hopes
08/11 MyoKardia's Strong Secondary Offering Flashes A Buy Signal
08/11 SANOFI'S ZIKA STANDOFF : Bad Medicine?
Financials (€)
Sales 2017 36 335 M
EBIT 2017 9 499 M
Net income 2017 7 865 M
Debt 2017 4 807 M
Yield 2017 3,70%
P/E ratio 2017 13,36
P/E ratio 2018 17,32
EV / Sales 2017 2,99x
EV / Sales 2018 2,89x
Capitalization 103 849 M
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Technical analysis trends SANOFI
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 86,0 €
Spread / Average Target 4,6%
EPS Revisions
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jérôme Contamine Chief Financial Officer & EVP-Finance
Elias A. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI6.97%122 127
JOHNSON & JOHNSON15.12%355 979
NOVARTIS7.69%216 915
ROCHE HOLDING LTD.3.78%216 699
PFIZER0.59%194 554